Evidence map›Paper›PMID 37571293›Full record

SynthesisNutrients2023

Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review.

Ana Laffond, Cristina Rivera-Picón, Pedro Manuel Rodríguez-Muñoz, Raúl Juárez-Vela, Regina Ruiz de Viñaspre-Hernández, Noelia Navas-Echazarreta, Juan Luis Sánchez-González

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07612852 (Digital Engagement for Lifelong Prevention and Health Improvement), which is not on this map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
26.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07612852 narecruitingnot on this mapstarted 2026, after this paper: background citation

Digital Engagement for Lifelong Prevention and Health Improvement

TypeinterventionalSponsorIstituto per la Ricerca e l'Innovazione BiomedicaRan2026 to 2027Enrolled200ConditionsLife Style, Healthy, Risk Reduction, Health PromotionArmsDELPHI Personalized Digital Prevention Platform, Passive Digital Monitoring Control
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Diabesity and Oral Immunity: Exploring the Interconnection.Advances in experimental medicine and biology · 2026
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ana LaffondDepartment of Medicine, University Hospital of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0002-1553-5652
Cristina Rivera-PicónFaculty of Health Sciences, Nursing, Pontifical University of Salamanca, 37002 Salamanca, Spain.
Pedro Manuel Rodríguez-MuñozFaculty of Nursing and Physiotherapy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0002-7933-952X
Raúl Juárez-VelaResearch Group GRUPAC, Nursing Department, Faculty of Heatlh Sciences, University of La Rioja, 26004 Logrono, Spain.ORCID 0000-0003-3597-2048
Regina Ruiz de Viñaspre-HernándezResearch Group GRUPAC, Nursing Department, Faculty of Heatlh Sciences, University of La Rioja, 26004 Logrono, Spain.ORCID 0000-0003-0345-8028
Noelia Navas-EchazarretaResearch Group GRUPAC, Nursing Department, Faculty of Heatlh Sciences, University of La Rioja, 26004 Logrono, Spain.
Juan Luis Sánchez-GonzálezFaculty of Nursing and Physiotherapy, University of Salamanca, 37008 Salamanca, Spain.ORCID 0000-0002-4791-6513
Universidad de La Rioja · ESUniversidad de Salamanca · ESUniversidad Pontificia de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) are currently the leading cause of mortality worldwide, with coronary heart disease being the primary cause. The Mediterranean Diet (MD) has been highlighted for its potential in providing greater protection against CVDs. This study aims to present an updated systematic review that examines the impact of MD on mortality and CVDs, both in the general population and in patients with a prior CVD, while also considering the potential influence of gender. We conducted a systematic review. After the selection process, 24 studies met the inclusion criteria. The findings from these studies consistently demonstrate that higher adherence to the MD is associated with a reduced risk of overall mortality, both in the general population and in patients with previous CVDs. Moreover, evidence suggests that following this dietary pattern likely decreases the risk of CVDs such as heart attacks, various types of coronary artery disease, stroke, and cardiovascular mortality. While some studies have identified differences in the benefits of the MD between men and women, it is important to note that these disparities may be attributed to lower event rates and a generally lower cardiovascular risk profile in women. Thus, the observed variations in outcomes should be interpreted in the context of these factors. Adherence to the MD has the potential to improve survival rates and reduce the risk of CVDs in both the general population and individuals with a prior CVD. Further research is needed to explore the specific mechanisms underlying the protective effects of this dietary pattern and to better understand the role gender-related differences in its outcomes. Nevertheless, promoting the adoption of the MD could be an effective strategy for mitigating the burden of CVDs globally.

Indexed as

Cardiovascular DiseasesCoronary Artery DiseaseDiet, MediterraneanFemaleHumansMalePrimary PreventionRisk FactorsSecondary Preventioncardiovascular diseaseMediterranean dietmortalitypreventionsystematic review

Identifiers

PMID37571293
PMCPMC10421390
OpenAlexW4385342229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.